»á̾:±ü¼±ÑÉ× ¤Î¸¡º÷·ë²Ì / 1 1 - 2 / 2 <<< 1 >>> / 1 1 - 2 / 2 <<< 1 >>> 1E06-09 2023/03/14 13:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E Reveromycin AÀ¸¹çÀ®¹ÚÁÇRevK-RevLÊ£¹çÂÎ¥â¥Ç¥ë¹½Â¤¤Ë´ð¤Å¤¯RevLÊÑ°Û¹ÚÁǤβòÀϤÈÁê¸ßºîÍÑÎΰè¤Î·èÄê Analysis of RevL mutants based on model structure of RevK-RevL complex involved in reveromycin biosynthesis and determination of their interaction regions ¡û²¬Â¼ ±Ñ¼£1¡¢º´Æ£¡Ê¼®ùõ¡Ë ͵Èþ1¡¢±ü¼ ±ÑÉ×2¡¢·§ºä ¿ò2¡¢Ä¹ÅÄ ÍµÇ·1¡¢¹â¶¶ ½ÓÆó1 ¡ûEiji OKAMURA1, Yumi SATO-SHIOZAKI1, Hideo OKUMURA2, Takashi KUMASAKA2, Hiroyuki OSADA1, TAKAHASHI Shunji1 1Íý¸¦CSRS¡¢2¹âµ±ÅÙ¸÷²Ê³Ø¸¦µæ¥»¥ó¥¿¡¼ 1RIKEN CSRS, 2JASRI 1F04-03 2023/03/14 10:30 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à F Furocoumarin·Ï²½¹çʪ£±¤ÎDHODHÆðÛŪÁ˳²µ¡¹½¤Î²òÌÀ Inhibition mechanism of furocoumarin–type compound 1 toward DHODH ¡ûÃ渶 ¼Â¶ê1¡¢ÅÏîµ Àµ¸ç1¡¢º´Æ£ Æ»Âç1¡¢±ü¼ ±ÑÉ×2¡¢Àîë À¿3¡¢Ä¹ÅÄ ÍµÇ·1,3¡¢ÅÏÊÕ ¸Æó1 ¡ûMIKU NAKAHARA1, Shogo Watanabe1, Michio Sato1, Hideo Okumura2, Makoto Kawatani3, Hiroyuki Osada1,3, Kenji Watanabe1 1ÀŲ¬¸©ÂçÌô¡¢2JASRI¡¢3Íý¸¦´Ä¶»ñ¸»¥» 1Dept. Pharm. Sci., Univ. Shizuoka, 2JASRI, 3RIKEN CSRS / 1 1 - 2 / 2 <<< 1 >>> / 1 1 - 2 / 2 <<< 1 >>>